543 related articles for article (PubMed ID: 32547365)
1. Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability.
Takamori M
Front Mol Neurosci; 2020; 13():86. PubMed ID: 32547365
[TBL] [Abstract][Full Text] [Related]
2. Roles of collagen Q in MuSK antibody-positive myasthenia gravis.
Ohno K; Otsuka K; Ito M
Chem Biol Interact; 2016 Nov; 259(Pt B):266-270. PubMed ID: 27119269
[TBL] [Abstract][Full Text] [Related]
3. Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling.
Otsuka K; Ito M; Ohkawara B; Masuda A; Kawakami Y; Sahashi K; Nishida H; Mabuchi N; Takano A; Engel AG; Ohno K
Sci Rep; 2015 Sep; 5():13928. PubMed ID: 26355076
[TBL] [Abstract][Full Text] [Related]
4. MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
Koneczny I; Cossins J; Waters P; Beeson D; Vincent A
PLoS One; 2013; 8(11):e80695. PubMed ID: 24244707
[TBL] [Abstract][Full Text] [Related]
5. [Genetic defects and disorders at the neuromuscular junction].
Ohno K
Brain Nerve; 2011 Jul; 63(7):669-78. PubMed ID: 21747136
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against Wnt receptor of muscle-specific tyrosine kinase in myasthenia gravis.
Takamori M; Nakamura T; Motomura M
J Neuroimmunol; 2013 Jan; 254(1-2):183-6. PubMed ID: 22999188
[TBL] [Abstract][Full Text] [Related]
7. [Editorial introduction: from the structure and functions of the neuromuscular junction to the diseases].
Takamori M
Brain Nerve; 2011 Jul; 63(7):635-40. PubMed ID: 21747132
[TBL] [Abstract][Full Text] [Related]
8. Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.
Pevzner A; Schoser B; Peters K; Cosma NC; Karakatsani A; Schalke B; Melms A; Kröger S
J Neurol; 2012 Mar; 259(3):427-35. PubMed ID: 21814823
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to agrin in myasthenia gravis patients.
Zhang B; Shen C; Bealmear B; Ragheb S; Xiong WC; Lewis RA; Lisak RP; Mei L
PLoS One; 2014; 9(3):e91816. PubMed ID: 24632822
[TBL] [Abstract][Full Text] [Related]
10. Synaptic Homeostasis and Its Immunological Disturbance in Neuromuscular Junction Disorders.
Takamori M
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28441759
[TBL] [Abstract][Full Text] [Related]
11. LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner.
Ohkawara B; Cabrera-Serrano M; Nakata T; Milone M; Asai N; Ito K; Ito M; Masuda A; Ito Y; Engel AG; Ohno K
Hum Mol Genet; 2014 Apr; 23(7):1856-68. PubMed ID: 24234652
[TBL] [Abstract][Full Text] [Related]
12. Myasthenia gravis experimentally induced with muscle-specific kinase.
Shigemoto K; Kubo S; Jie C; Hato N; Abe Y; Ueda N; Kobayashi N; Kameda K; Mominoki K; Miyazawa A; Ishigami A; Matsuda S; Maruyama N
Ann N Y Acad Sci; 2008; 1132():93-8. PubMed ID: 18096854
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis.
Shen C; Lu Y; Zhang B; Figueiredo D; Bean J; Jung J; Wu H; Barik A; Yin DM; Xiong WC; Mei L
J Clin Invest; 2013 Dec; 123(12):5190-202. PubMed ID: 24200689
[TBL] [Abstract][Full Text] [Related]
14. The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses.
Tezuka T; Inoue A; Hoshi T; Weatherbee SD; Burgess RW; Ueta R; Yamanashi Y
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16556-61. PubMed ID: 25368159
[TBL] [Abstract][Full Text] [Related]
15. Characterization of LRP4/Agrin Antibodies From a Patient With Myasthenia Gravis.
Yu Z; Zhang M; Jing H; Chen P; Cao R; Pan J; Luo B; Yu Y; Quarles BM; Xiong W; Rivner MH; Mei L
Neurology; 2021 Sep; 97(10):e975-e987. PubMed ID: 34233932
[TBL] [Abstract][Full Text] [Related]
16. MuSk function during health and disease.
Herbst R
Neurosci Lett; 2020 Jan; 716():134676. PubMed ID: 31811897
[TBL] [Abstract][Full Text] [Related]
17. Myasthenia Gravis With Antibodies Against Muscle Specific Kinase: An Update on Clinical Features, Pathophysiology and Treatment.
Cao M; Koneczny I; Vincent A
Front Mol Neurosci; 2020; 13():159. PubMed ID: 32982689
[TBL] [Abstract][Full Text] [Related]
18. Agrin/Lrp4 signal constrains MuSK-dependent neuromuscular synapse development in appendicular muscle.
Walker LJ; Roque RA; Navarro MF; Granato M
Development; 2021 Nov; 148(21):. PubMed ID: 34714331
[TBL] [Abstract][Full Text] [Related]
19. [Autoantibodies in myasthenia gravis].
Motomura M; Narita Masuda T
Brain Nerve; 2013 Apr; 65(4):433-9. PubMed ID: 23568991
[TBL] [Abstract][Full Text] [Related]
20. The collagen ColQ binds to LRP4 and regulates the activation of the Muscle-Specific Kinase-LRP4 receptor complex by agrin at the neuromuscular junction.
Uyen Dao TM; Barbeau S; Messéant J; Della-Gaspera B; Bouceba T; Semprez F; Legay C; Dobbertin A
J Biol Chem; 2023 Aug; 299(8):104962. PubMed ID: 37356721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
